risankizumab

Ukraine

Drugs containing this active substance

  • SKYRIZI

    The drug is used to treat adults with moderate to severe plaque psoriasis, as well as for the treatment of active psoriatic arthritis (either alone or in combination with methotrexate).

    Form: solution for injection

    Active substance Dosage
    risankizumab 150 mg/ml

    ATC: L04AC18

    Manufacturer: AbbVie Biotechnology Ltd (manufacturing of medicinal product, testing, primary packaging)